B-Lymphocytes

B cell depletion impairs vaccination-induced CD8⁺ T cell responses in a type I interferon-dependent manner
Theresa Graalmann, Katharina Borst, Himanshu Manchanda, Lea Vaas, Matthias Bruhn, Lukas Graalmann, Mario Koster, Murielle Verboom, Michael Hallensleben, Carlos Alberto Guzmán, Gerd Sutter, Reinhold E Schmidt, Torsten Witte, Ulrich Kalinke

Annals of the Rheumatic Diseases Jul 2021, annrheumdis-2021-220435; DOI: 10.1136/annrheumdis-2021-220435
B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus
Scott A Jenks, Chungwen Wei, Regina Bugrovsky, Aisha Hill, Xiaoqian Wang, Francesca M Rossi, Kevin Cashman, Matthew C Woodruff, Laura D Aspey, S. Sam Lim, Gaobin Bao, Cristina Drenkard, Ignacio Sanz

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220349; DOI: 10.1136/annrheumdis-2021-220349
Correspondence on ‘Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
Chiara Salviani, Francesco Scolari, Federico Alberici

Annals of the Rheumatic Diseases May 2021, annrheumdis-2021-220496; DOI: 10.1136/annrheumdis-2021-220496
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab
Silvia Suárez-Díaz, Claudia Morán-Castaño, Rubén Coto-Hernández, Lourdes Mozo-Avellaneda, Carlos Suárez-Cuervo, Luis Caminal-Montero

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e99; DOI: 10.1136/annrheumdis-2020-218246
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response
Michael Markus Bonelli, Daniel Mrak, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha

Annals of the Rheumatic Diseases May 2021, annrheumdis-2021-220408; DOI: 10.1136/annrheumdis-2021-220408
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht, Rebecca Hasseli, Alla Skapenko

Annals of the Rheumatic Diseases May 2021, 80 (5) e67; DOI: 10.1136/annrheumdis-2020-218075
Response to: ‘Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab’ by Avouac et al
Philippe Guilpain, Clément Le Bihan, Vincent Foulongne, Patrice Taourel, Nathalie Pansu, Alexandre Thibault Jacques Maria, Boris Jung, Romaric Larcher, Kada Klouche, Vincent Le Moing

Annals of the Rheumatic Diseases Mar 2021, 80 (3) e38; DOI: 10.1136/annrheumdis-2020-217955
Response to: ‘Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’’ by Parikh et al
Rona M Smith, Peter A Merkel, David Jayne

Annals of the Rheumatic Diseases Feb 2021, annrheumdis-2020-219329; DOI: 10.1136/annrheumdis-2020-219329
Response to: ‘Correspondence on ‘Jan Gösta Waldenströmand rheumatology’’ by Moutsopoulos
Frank A Wollheim

Annals of the Rheumatic Diseases Dec 2020, annrheumdis-2020-219579; DOI: 10.1136/annrheumdis-2020-219579
Correspondence on ‘Jan Gösta Waldenström and rheumatology’
Haralampos M Moutsopoulos

Annals of the Rheumatic Diseases Dec 2020, annrheumdis-2020-219508; DOI: 10.1136/annrheumdis-2020-219508

Main menu

B-Lymphocytes

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

B-Lymphocytes

Pages